% Expired Patents = 40.0

EPO Patents = 3

Forward Citations = 7

Loading Chart...

10 inventors (with patents filed for the assignee):

Amato J Giaccia (4 out of 20 patents)

Mihalis S Kariolis (4 out of 14 patents)

Yu Rebecca Miao (4 out of 8 patents)

4. Jennifer R Cochran (3 out of 42 patents)

5. Katherine Cynthia Fuh (3 out of 6 patents)

6. Raymond Tabibiazar (3 out of 6 patents)

7. Erinn Bruno Rankin (3 out of 6 patents)

8. Douglas Scott Jones (3 out of 50 patents)

9. Susan Hershenson (2 out of 2 patents)

10. Patrick O'Connor (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11136563 - Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy (2021-10-05),

2. 10876176 - Antifibrotic activity of GAS6 inhibitor (2020-12-29),

3. 10137173 - Antiviral activity of Gas6 inhibitor (2018-11-27),

4. 9879061 - Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis (2018-01-30),

5. 9822347 - Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy (2017-11-21),

Company Overview

Aravive Biologics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies that target critical pathways in the treatment of cancer and fibrosis. The company's lead product candidate, AVB-500, is currently being evaluated in multiple clinical trials for various solid tumors.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#844 in Houston, TX

#3,331 in Texas

#51,620 in US

Houston, TX, United States of America

Aravive Biologics, Inc.

Forward Citations = 7

10 inventors:

Amato J Giaccia (4 out of 20 patents)

Mihalis S Kariolis (4 out of 14 patents)

Yu Rebecca Miao (4 out of 8 patents)

4. Jennifer R Cochran (3 out of 42 patents)

5. Katherine Cynthia Fuh (3 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aravive Biologics, Inc.. Retrieved from https://idiyas.com/company/aravive-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]